Structure-based virtual screening

Current Drug Targets

Volumn 11, Issue 3, 2010, Pages 261-263

  De Azevedo Jr , Walter Filgueira ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; PURINE NUCLEOSIDE PHOSPHORYLASE; SHIKIMIC ACID;

ALGORITHM; BINDING AFFINITY; COMPUTER MODEL; DRUG DESIGN; DRUG IDENTIFICATION; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; EDITORIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; METHODOLOGY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; SCREENING; STRUCTURE BASED VIRTUAL SCREENING; THERMODYNAMICS; VIRTUAL REALITY; X RAY CRYSTALLOGRAPHY;

COMPUTER SIMULATION; DATABASES, PROTEIN; DIRECTED MOLECULAR EVOLUTION; DRUG DESIGN; DRUG DISCOVERY; EVOLUTION, MOLECULAR; FORECASTING; HUMANS; LIBRARIES, DIGITAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN ENGINEERING; RECEPTORS, DRUG; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77950854861     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945010790711969     Document Type: Editorial

References (30)

1. Tanrikulu Y, Schneider G. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Nat Rev Drug Discov 2008; 7: 667-677
2. De Azevedo Jr WF. Targets for development of drugs against orphan diseases. Curr Drug Targets 2008; 9: 1030-1130
3. Canduri F, De Azevedo Jr WF. Structural basis for interaction of inhibitors with Cyclin-Dependent Kinase 2. Curr Computer-Aided Drug Design 2005; 1: 53-64.
4. Ferrara P, Priestle JP, Vangrevelinghe E, Jacoby E. New developments and applications of docking and high-throughput docking for drug design and in silico screening. Curr Computer-Aided Drug Design 2006; 2: 83-91. (Pubitemid 44082934)
5. Canduri F, De Azevedo Jr WF. Protein crystallography in drug discovery. Curr Drug Targets 2008; 9: 1048-1053
6. Timmers LFS, Pauli I, Caceres RA, De Azevedo Jr WF. Drug-binding databases. Curr Drug Targets 2008; 9: 1092-1099
7. Sanbonmatsu KY, Tung CS. High performance computing in biology: multimillion atom simulations of nanoscale systems. J Struct Biol 2007; 157: 470-480 (Pubitemid 46304255)
8. Okimoto N, Futatsugi N, Fuji H, et al. High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations. PLOS Comput Biol 2009; 5 :e1000528-8.
9. De Amorim HL, Caceres RA, Netz PA. Linear interaction energy (LIE) method in lead discovery and optimization. Curr Drug Targets 2008; 9: 1100-1105
10. Dias R, De Azevedo Jr WF. Molecular docking algorithms. Curr Drug Targets 2008; 9: 1040-1047
11. Floudas CA. Research challenges, opportunities and synergism in systems engineering and computational biology. AIChE Journal 2005; 51: 1872-1884 (Pubitemid 41334682)
12. Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem 2006; 49: 3315-3321 (Pubitemid 43830529)
13. Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking. Proteins 2004; 55: 288-304.
14. Pauli I, Timmers LFSM, Caceres RA, Soares MBP, De Azevedo Jr WF. In silico and in vitro. Identifying new drugs. Curr Drug Targets 2008; 9: 1054-1061
15. Dias R, Timmers LFSM, Caceres RA, De Azevedo Jr WF. Evaluation of molecular docking using polynomial empirical scoring functions. Curr Drug Targets 2008; 9: 1062-1070
16. De Azevedo Jr WF, Dias R. Experimental approaches to evaluate the thermodynamics of protein-drug interactions. Curr Drug Targets 2008; 9: 1071-1076
17. Caceres RA, Pauli I, Timmers LFS, De Azevedo Jr WF. Molecular recognition models: A challenge to overcome. Curr Drug Targets 2008; 9: 1077-1083
18. Barcellos GB, Pauli I, Caceres RA, Timmers LFS, Dias R, De Azevedo Jr WF. Molecular modeling as tool for drug discovery. Curr Drug Targets 2008; 9: 1084-1091
19. De Azevedo Jr WF, Dias R, Timmers LFSM, Pauli I, Caceres RA, Soares MBP. Bioinformatics tools for screening of antiparasitic drugs. Curr Drug Targets 2009; 10: 232-239
20. De Azevedo Jr WF, Soares MBP. Selection of targets for drug development against protozoan parasites. Curr Drug Targets 2009; 10: 193-201.
21. Timmers LFSM, Pauli I, Barcellos GB, et al. Genomic databases and the search of protein targets for protozoan. Curr Drug Targets 2009; 10: 240-245
22. De Azevedo Jr. WF, Caceres RA, Pauli I, et al. Protein-drug interaction studies for development of drugs against Plasmodium falciparum. Curr Drug Targets 2009; 10: 271-278
23. Canduri F, Uchoa HB, De Azevedo Jr WF. Molecular models of cyclin-dependent kinase 1 complexed with inhibitors. Biochem Biophys Res Commun 2004; 324: 661-666 (Pubitemid 39345567)
24. Canduri F, Fadel V, Basso LA, Palma MS, Santos DS, De Azevedo Jr WF. New catalytic mechanism for human purine nucleoside phosphorylase. Biochem Biophys Res Commun 2005; 327: 646-649 (Pubitemid 40092798)
25. Pereira JH, Canduri F, de Oliveira JS, et al. Structural Bioinformatics Study of EPSP synthase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 2003; 312: 608-614
26. De Azevedo Jr WF, Canduri F, dos Santos DM, et al. Crystal structure of human PNP complexed with guanine. Biochem Biophys Res Commun 2003; 312: 767-772
27. De Azevedo Jr WF, Canduri F, Dos Santos D.M, et al. Structural basis for inhibition of human PNP by immucillin-H. Biochem Biophys Res Commun 2003; 309: 917-922 (Pubitemid 37122617)
28. De Azevedo Jr WF, Canduri F, Simões de Oliveira J, et al. Molecular model of shikimate kinase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 2002; 295: 142-148
29. Canduri F, Teodoro LG, Fadel V, et al. Structure of human uropepsin at 2.45 A resolution. Acta Crystallogr D Biol Crystallogr 2001; 57: 1560-1570 (Pubitemid 33037719)
30. Canduri F, Silva RG, dos Santos DM, et al. Structure of human PNP complexed with ligands. Acta Crystallogr D Biol Crystallogr 2005; 61: 856-862